Montana Attorney General Tim Fox announces a $5.9 million legal settlement with subsidiaries of Johnson & Johnson in Helena, Mont., on Thursday, March 6, 2014. The state’s lawsuit claimed Janssen Ortho LLC and Janssen Pharmaceuticals hid the dangers of the antipsychotic drug Risperdal and promoted it for uses not approved by the Food and Drug Administration. (AP Photo/Matt Volz)
HELENA, Mont. (AP) — Subsidiaries of Johnson & Johnson have agreed to pay $5.9 million to settle a lawsuit with Montana over how an anti-psychotic drug was marketed, state Attorney General Tim Fox said Thursday.
The settlement with Janssen Ortho LLC and Janssen Pharmaceuticals closes the latest in a string of lawsuits across the nation over the drug Risperdal, including a $2.2 billion settlement in November with the U.S. Department of Justice.
The companies knew the drug had the potential to cause weight gain, diabetes and Login to read more